Validate skin tone improvement and radiance claims with market-ready protocols trusted by global retailers and compliant with EU Common Criteria + EU 1223/2009 (PIF), FTC advertising substantiation, and MoCRA safety substantiation.
ALS designs clinical testing pathways to substantiate brightening and tone-evening claims across a range of product formats. Claims such as “boosts glow,” “reduces discoloration,” and “visibly brightens” are supported by non-invasive instrumentation, clear endpoints, and formatted outputs aligned to retail and regulatory expectations.
We align each protocol with your product format and go-to-market plan, helping brands accelerate launches while minimizing relabeling or rework. Whether you are optimizing a hero SKU or testing multiple formats, scalable bundles and expert consultation guide you from feasibility to final report, without adding friction.
Process for skin brightening and even tone claims testing
Not in every case. Substantiation is expected under MoCRA, EU Common Criteria, EU 1223/2009 PIF, and FTC standards. ALS confirms which test types align to your claims and markets.
Retailers often require quantitative proof. ALS uses validated instruments to provide measurable data that withstands QA and regulatory review.
No, if scoped early. ALS offers fast test setup, feasibility reviews, and efficient reporting to fit launch timelines.
Yes. Reports are structured for retailer submissions, PDPs, and investor decks, with optional imagery and summaries for visual impact.